1-8 of 8
Yicheng Zhang, MD PhD
Close
Sort by
Journal Articles

Role of Folate Receptor 3 in Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia

Na Shen, Xiaojian Zhu, Shu Zhou, Yong You, PhD, Zhaodong Zhong, PhD, Xiaoying Zhu, Qing Li, PhD, Ping Zou, PhD, Yicheng Zhang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2998.
https://doi.org/10.1182/blood-2018-99-111611
Published: 2018
Journal Articles

SHP-1 As a Negative Regulator of FLT3 Associated Aberrant Signaling and a New Potential Target to FLT3-ITD Mutation

Tongjuan Li, MD PhD, Dan Li, Lei Zhao, MD, Jue Wang, MD PhD, Zhen Shang, MD PhD, Yicheng Zhang, MD PhD, Liang Huang, MD PhD, Jianfeng Zhou, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4051.
https://doi.org/10.1182/blood-2018-99-115793
Published: 2018
Journal Articles

Droplet Digital PCR Monitoring of TP53 Mutated Circulating Tumor DNA Levels in Lymphoma Patients

Xiaolu Long, Jia Gu, Yaoyao Lou, Qian Xu, Haodong Cai, MD, Wei Zhang, MD, Kefeng Shen, Min Xiao, MD PhD, Yicheng Zhang, MD PhD, Liting Chen, PhD, Jianfeng Zhou, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4106.
https://doi.org/10.1182/blood-2018-99-113825
Published: 2018
Journal Articles

Targeting Burkitt Lymphoma By CAR-Extracellular Vesicles: A Tropism-Delivery Platform for CRISPR/Cas9 System

Qian Xu, Zheng Zhang, MD, Lei Zhao, MD, Yun Qin, Yicheng Zhang, MD PhD, Jue Wang, MD PhD, Jianfeng Zhou, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3487.
https://doi.org/10.1182/blood-2018-99-115003
Published: 2018
Journal Articles

Clinical and Genetic Features of Epstein-Barr Virus-Triggered Late-Onset Primary Hemophagocytic Lymphohistiocytosis: 10 Pedigrees Study

Chunrui Li, MD PhD, Lili Gao, Li Yang, Min Xiao, MD PhD, Jianfeng Zhou, MD PhD, Yicheng Zhang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3903.
https://doi.org/10.1182/blood-2018-99-114009
Published: 2018
Journal Articles

Retrospective Analysis of Chinese Chronic Myeloid Leukemia Patients Who Have Stopped Tyrosine Kinase Inhibitors

Xiaojian Zhu, Yong You, PhD, Yicheng Zhang, MD PhD, Minghui Duan, MD, Yu Zhu, MD PhD, Bingcheng Liu, MD, Xin Du, MD, Suning Chen, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5443.
https://doi.org/10.1182/blood-2018-99-113854
Published: 2018
Journal Articles

Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells Following Autologous HSCT in Patients with B-NHL

Yang Cao, Na Wang, MD PhD, Gaoxiang Wang, MD PhD, Yi Xiao, MD PhD, Liang Huang, MD PhD, Chunrui Li, MD PhD, Min Xiao, MD PhD, Tongcun Zhang, PhD, Yicheng Zhang, MD PhD, Jianfeng Zhou, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2054.
https://doi.org/10.1182/blood-2018-99-113827
Published: 2018
Journal Articles

Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for Adult Patients with Refractory/Relapsed B-Cell Acute Lymphoblastic Leukemia

Liang Huang, MD PhD, Na Wang, MD PhD, Chunrui Li, MD PhD, Yang Cao, MD PhD, Yi Xiao, MD PhD, Min Xiao, MD PhD, Yicheng Zhang, MD PhD, Tongcun Zhang, PhD, Jianfeng Zhou, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 846.
https://doi.org/10.1182/blood.V130.Suppl_1.846.846
Published: 2017